These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 9259992)
1. The role of oxidative stress in the long-term glycation of LDL. Menzel EJ; Sobal G; Staudinger A Biofactors; 1997; 6(2):111-24. PubMed ID: 9259992 [TBL] [Abstract][Full Text] [Related]
2. Why is glycated LDL more sensitive to oxidation than native LDL? A comparative study. Sobal G; Menzel J; Sinzinger H Prostaglandins Leukot Essent Fatty Acids; 2000 Oct; 63(4):177-86. PubMed ID: 11049692 [TBL] [Abstract][Full Text] [Related]
3. In vivo and in vitro evidence for the glycoxidation of low density lipoprotein in human atherosclerotic plaques. Imanaga Y; Sakata N; Takebayashi S; Matsunaga A; Sasaki J; Arakawa K; Nagai R; Horiuchi S; Itabe H; Takano T Atherosclerosis; 2000 Jun; 150(2):343-55. PubMed ID: 10856526 [TBL] [Abstract][Full Text] [Related]
4. The role of antioxidants in the long-term glycation of low density lipoprotein and its Cu2+-catalyzed oxidation. Sobal G; Menzel J Free Radic Res; 2000 May; 32(5):439-49. PubMed ID: 10766412 [TBL] [Abstract][Full Text] [Related]
5. Lipid advanced glycosylation: pathway for lipid oxidation in vivo. Bucala R; Makita Z; Koschinsky T; Cerami A; Vlassara H Proc Natl Acad Sci U S A; 1993 Jul; 90(14):6434-8. PubMed ID: 8341651 [TBL] [Abstract][Full Text] [Related]
6. Glyc-oxidized LDL impair endothelial function more potently than oxidized LDL: role of enhanced oxidative stress. Galle J; Schneider R; Winner B; Lehmann-Bodem C; Schinzel R; Münch G; Conzelmann E; Wanner C Atherosclerosis; 1998 May; 138(1):65-77. PubMed ID: 9678772 [TBL] [Abstract][Full Text] [Related]
7. Effect of alpha-tocopherol on LDL oxidation and glycation: in vitro and in vivo studies. Li D; Devaraj S; Fuller C; Bucala R; Jialal I J Lipid Res; 1996 Sep; 37(9):1978-86. PubMed ID: 8895064 [TBL] [Abstract][Full Text] [Related]
8. In vitro kinetic studies of formation of antigenic advanced glycation end products (AGEs). Novel inhibition of post-Amadori glycation pathways. Booth AA; Khalifah RG; Todd P; Hudson BG J Biol Chem; 1997 Feb; 272(9):5430-7. PubMed ID: 9038143 [TBL] [Abstract][Full Text] [Related]
9. Calcium antagonists as inhibitors of in vitro low density lipoprotein oxidation and glycation. Sobal G; Menzel EJ; Sinzinger H Biochem Pharmacol; 2001 Feb; 61(3):373-9. PubMed ID: 11172743 [TBL] [Abstract][Full Text] [Related]
10. Glycation and glycoxidation of low-density lipoproteins by glucose and low-molecular mass aldehydes. Formation of modified and oxidized particles. Knott HM; Brown BE; Davies MJ; Dean RT Eur J Biochem; 2003 Sep; 270(17):3572-82. PubMed ID: 12919321 [TBL] [Abstract][Full Text] [Related]
11. Kinetics of nonenzymatic glycation of ribonuclease A leading to advanced glycation end products. Paradoxical inhibition by ribose leads to facile isolation of protein intermediate for rapid post-Amadori studies. Khalifah RG; Todd P; Booth AA; Yang SX; Mott JD; Hudson BG Biochemistry; 1996 Apr; 35(15):4645-54. PubMed ID: 8664253 [TBL] [Abstract][Full Text] [Related]
12. Immunochemical studies on native and glycated LDL - An approach to uncover the structural perturbations. Khan MY; Alouffi S; Ahmad S Int J Biol Macromol; 2018 Aug; 115():287-299. PubMed ID: 29634967 [TBL] [Abstract][Full Text] [Related]
13. 2'-Deoxyribose Mediated Glycation Leads to Alterations in BSA Structure Via Generation of Carbonyl Species. Rafi Z; Alouffi S; Khan MS; Ahmad S Curr Protein Pept Sci; 2020; 21(9):924-935. PubMed ID: 32053073 [TBL] [Abstract][Full Text] [Related]
14. Presence of dopa and amino acid hydroperoxides in proteins modified with advanced glycation end products (AGEs): amino acid oxidation products as a possible source of oxidative stress induced by AGE proteins. Fu S; Fu MX; Baynes JW; Thorpe SR; Dean RT Biochem J; 1998 Feb; 330 ( Pt 1)(Pt 1):233-9. PubMed ID: 9461515 [TBL] [Abstract][Full Text] [Related]
15. What is the effect of hyperglycemia on atherogenesis and can it be reversed by aminoguanidine? Bucala R Diabetes Res Clin Pract; 1996 Feb; 30 Suppl():123-30. PubMed ID: 8964186 [TBL] [Abstract][Full Text] [Related]
16. Hydroxyalkenal formation induced by advanced glycosylation of low density lipoprotein. Al-Abed Y; Liebich H; Voelter W; Bucala R J Biol Chem; 1996 Feb; 271(6):2892-6. PubMed ID: 8621676 [TBL] [Abstract][Full Text] [Related]
17. The advanced glycation end product, Nepsilon-(carboxymethyl)lysine, is a product of both lipid peroxidation and glycoxidation reactions. Fu MX; Requena JR; Jenkins AJ; Lyons TJ; Baynes JW; Thorpe SR J Biol Chem; 1996 Apr; 271(17):9982-6. PubMed ID: 8626637 [TBL] [Abstract][Full Text] [Related]
18. Genistein prevents the glucose autoxidation mediated atherogenic modification of low density lipoprotein. Exner M; Hermann M; Hofbauer R; Kapiotis S; Quehenberger P; Speiser W; Held I; Gmeiner BM Free Radic Res; 2001 Jan; 34(1):101-12. PubMed ID: 11234992 [TBL] [Abstract][Full Text] [Related]
19. The effects of glycation/glycoxidation on the liberation of 8-epi-PGF2alpha from low density lipoprotein during its in vitro oxidation. Sobal G; Menzel EJ; Sinzinger H Prostaglandins Leukot Essent Fatty Acids; 2000 Apr; 62(4):217-24. PubMed ID: 10882185 [TBL] [Abstract][Full Text] [Related]
20. Modification of low density lipoprotein by advanced glycation end products contributes to the dyslipidemia of diabetes and renal insufficiency. Bucala R; Makita Z; Vega G; Grundy S; Koschinsky T; Cerami A; Vlassara H Proc Natl Acad Sci U S A; 1994 Sep; 91(20):9441-5. PubMed ID: 7937786 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]